| Apogee Therapeutics, Inc. | 1.2M | US$160M | 1.5% |
| Moderna, Inc. | 2.16M | US$152M | 1.4% |
| Twist Bioscience Corporation | 1.47M | US$151M | 1.4% |
| Oruka Therapeutics, Inc. | 1.56M | US$148M | 1.4% |
| Kymera Therapeutics, Inc. | 1.27M | US$146M | 1.4% |
| Viking Therapeutics, Inc. | 3.59M | US$140M | 1.3% |
| Praxis Precision Medicines, Inc. | 414K | US$139M | 1.3% |
| Erasca, Inc. | 7.45M | US$136M | 1.3% |
| Revolution Medicines, Inc. | 690K | US$129M | 1.2% |
| Rhythm Pharmaceuticals, Inc. | 1.16M | US$129M | 1.2% |
| Cg Oncology, Inc. | 1.81M | US$129M | 1.2% |
| Sellas Life Sciences Group, Inc. | 8.65M | US$128M | 1.2% |
| Vaxcyte, Inc. | 2.19M | US$127M | 1.2% |
| Dianthus Therapeutics, Inc. | 1.3M | US$127M | 1.2% |
| Cytokinetics, Incorporated | 1.48M | US$126M | 1.2% |
| Natera, Inc. | 460K | US$125M | 1.2% |
| Scholar Rock Holding Corporation | 2.26M | US$124M | 1.2% |
| Roivant Sciences Ltd. | 3.5M | US$124M | 1.2% |
| Mirum Pharmaceuticals, Inc. | 1.06M | US$124M | 1.2% |
| Cogent Biosciences, Inc. | 3.17M | US$123M | 1.1% |
| Ultragenyx Pharmaceutical Inc. | 3.67M | US$122M | 1.1% |
| Travere Therapeutics, Inc. | 2.13M | US$121M | 1.1% |
| Alkermes Plc | 2.27M | US$119M | 1.1% |
| Krystal Biotech, Inc. | 319K | US$118M | 1.1% |
| Celcuity Inc. | 1.13M | US$118M | 1.1% |
| Relay Therapeutics, Inc. | 6.3M | US$118M | 1.1% |
| Spyre Therapeutics, Inc. | 1.33M | US$118M | 1.1% |
| Tg Therapeutics, Inc. | 2.14M | US$117M | 1.1% |
| Beam Therapeutics Inc. | 3.38M | US$116M | 1.1% |
| Insmed Incorporated | 1.08M | US$116M | 1.1% |
| Protagonist Therapeutics, Inc. | 941K | US$115M | 1.1% |
| Arrowhead Pharmaceuticals, Inc. | 1.41M | US$115M | 1.1% |
| Vera Therapeutics, Inc. | 2.65M | US$114M | 1.1% |
| Vertex Pharmaceuticals Incorporated | 228K | US$113M | 1.1% |
| Madrigal Pharmaceuticals, Inc. | 211K | US$113M | 1.1% |
| Abbvie Inc. | 443K | US$111M | 1.0% |
| Biogen Inc. | 513K | US$111M | 1.0% |
| Ptc Therapeutics, Inc. | 1.36M | US$111M | 1.0% |
| Halozyme Therapeutics, Inc. | 1.41M | US$111M | 1.0% |
| Uniqure N.v. | 2.4M | US$110M | 1.0% |
| Bridgebio Pharma, Inc. | 1.48M | US$110M | 1.0% |
| Crispr Therapeutics Ag | 2.01M | US$110M | 1.0% |
| Immunitybio, Inc. | 12.5M | US$109M | 1.0% |
| Summit Therapeutics Inc. | 7.45M | US$109M | 1.0% |
| Ionis Pharmaceuticals, Inc. | 1.36M | US$108M | 1.0% |
| Incyte Corporation | 945K | US$107M | 1.00% |
| Amgen Inc. | 295K | US$107M | 0.99% |
| Neurocrine Biosciences, Inc. | 619K | US$104M | 0.97% |
| Gilead Sciences, Inc. | 820K | US$104M | 0.96% |
| Regeneron Pharmaceuticals, Inc. | 165K | US$103M | 0.96% |
| Exelixis, Inc. | 1.89M | US$103M | 0.96% |
| Alnylam Pharmaceuticals, Inc. | 342K | US$103M | 0.96% |
| Biomarin Pharmaceutical Inc. | 1.77M | US$101M | 0.94% |
| Acadia Pharmaceuticals Inc. | 3.98M | US$101M | 0.94% |
| Nuvalent, Inc. | 807K | US$99.7M | 0.93% |
| Immunovant, Inc. | 2.58M | US$99.3M | 0.92% |
| United Therapeutics Corporation | 183K | US$99.2M | 0.92% |
| Intellia Therapeutics, Inc. | 5.76M | US$97.4M | 0.91% |
| Grail, Inc. | 1.43M | US$97.3M | 0.91% |
| Biocryst Pharmaceuticals, Inc. | 9.58M | US$95.8M | 0.89% |
| Catalyst Pharmaceuticals, Inc. | 2.99M | US$93.8M | 0.87% |
| Dyne Therapeutics, Inc. | 4.15M | US$92.2M | 0.86% |
| Tango Therapeutics, Inc. | 2.89M | US$90.4M | 0.84% |
| Denali Therapeutics Inc. | 3.48M | US$89.4M | 0.83% |
| Veracyte, Inc. | 1.5M | US$87.9M | 0.82% |
| Ideaya Biosciences, Inc. | 2.31M | US$86.3M | 0.80% |
| Recursion Pharmaceuticals, Inc. | 22.1M | US$81.2M | 0.76% |
| Sarepta Therapeutics, Inc. | 4.46M | US$80.2M | 0.75% |
| Arcus Biosciences, Inc. | 2.59M | US$79.8M | 0.74% |
| Syndax Pharmaceuticals, Inc. | 3.53M | US$77.1M | 0.72% |
| Arcutis Biotherapeutics, Inc. | 2.91M | US$76.4M | 0.71% |
| Mineralys Therapeutics, Inc. | 2.82M | US$76.1M | 0.71% |
| Celldex Therapeutics, Inc. | 2.03M | US$75.4M | 0.70% |
| Agios Pharmaceuticals, Inc. | 2.01M | US$74.4M | 0.69% |
| Viridian Therapeutics, Inc. | 3.92M | US$72.1M | 0.67% |
| Novavax, Inc. | 7.53M | US$70.9M | 0.66% |
| Disc Medicine, Inc. | 959K | US$70.1M | 0.65% |
| Adma Biologics Inc | 7.79M | US$65.2M | 0.61% |
| Immunome, Inc. | 2.99M | US$63.4M | 0.59% |
| Palvella Therapeutics, Inc. | 409K | US$62.5M | 0.58% |
| Iovance Biotherapeutics, Inc. | 14.5M | US$60.3M | 0.56% |
| Absci Corporation | 5.17M | US$59.9M | 0.56% |
| Nurix Therapeutics, Inc. | 2.46M | US$59.7M | 0.56% |
| Kodiak Sciences Inc | 1.5M | US$58.3M | 0.54% |
| Biohaven Ltd. | 3.79M | US$56.4M | 0.53% |
| Vericel Corporation | 1.19M | US$53.1M | 0.49% |
| Anaptysbio, Inc. | 787K | US$53.1M | 0.49% |
| Capricor Therapeutics, Inc. | 2.18M | US$52.5M | 0.49% |
| Stoke Therapeutics, Inc. | 1.57M | US$51.5M | 0.48% |
| Monte Rosa Therapeutics, Inc. | 2.11M | US$51.2M | 0.48% |
| Vir Biotechnology, Inc. | 4.95M | US$50.4M | 0.47% |
| Hyperliquid Strategies Inc | 6.33M | US$49.8M | 0.46% |
| Tyra Biosciences, Inc. | 1.39M | US$44.5M | 0.41% |
| Corvus Pharmaceuticals, Inc. | 2.93M | US$43.8M | 0.41% |
| Cullinan Therapeutics, Inc. | 2.38M | US$43.3M | 0.40% |
| Precigen, Inc. | 7.09M | US$40.4M | 0.38% |
| Inhibrx Biosciences, Inc. | 401K | US$38M | 0.35% |
| Taysha Gene Therapies, Inc. | 5.57M | US$37.9M | 0.35% |
| Ardelyx, Inc. | 7.42M | US$37.8M | 0.35% |
| Avalo Therapeutics, Inc. | 2.03M | US$37.5M | 0.35% |